Cargando...
The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia
Recurrent mutations affecting cellular metabolism and epigenetic regulation are implicated in the pathogenesis of acute myeloid leukemia (AML). Isocitrate dehydrogenase 2 (IDH2) gene mutations are described in 12% of patients with AML and 5% of patients with myelodysplastic syndromes. IDH2 enzyme is...
Guardado en:
| Publicado en: | Ther Adv Hematol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6041864/ https://ncbi.nlm.nih.gov/pubmed/30013764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620718777467 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|